Thursday, 24 May 2018

FDA declines to approve Recro Pharma's non-opioid pain shot

The U.S. Food and Drug Administration on Thursday declined to approve Recro Pharma's IV meloxicam noting the pain-relieving effect of the drug did not meet its expectations.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)